These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4835101)

  • 1. Influence of tumor size and surgical resection on cell-mediated immunity in mice.
    Whitney RB; Levy JG; Smith AG
    J Natl Cancer Inst; 1974 Jul; 53(1):111-6. PubMed ID: 4835101
    [No Abstract]   [Full Text] [Related]  

  • 2. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of tumor growth in an "immunologically privileged site" by adoptive transfer of tumor-specific transplantation immunity.
    Futrell JW; Albright NL; Myers GH
    J Surg Res; 1972 Feb; 12(2):62-9. PubMed ID: 5012043
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the effector cell of anti-tumour immunity in a chemically induced mouse tumour system.
    Whitney RB; Levy JG; Smith AG
    Br J Cancer; 1975 Feb; 31(2):157-63. PubMed ID: 1080668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherent cells in tumor immunity.
    Burk MW; Burk KR; Yu S; McKhann CF
    Cell Immunol; 1977 Apr; 30(1):43-53. PubMed ID: 862034
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME
    J Natl Cancer Inst; 1974 Dec; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered host-allograft relationships for mouse tumors modified by prior passage in vitro and in vivo. II. Reactivity of lymphoid cells.
    Jacobs BB
    J Natl Cancer Inst; 1972 Oct; 49(4):1085-91. PubMed ID: 4404346
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response to a transplantable malignant melanoma in mice.
    Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
    J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of anti-transplantation immunity of tumor.
    Ito T
    Acta Pathol Jpn; 1968 May; 18(2):207-25. PubMed ID: 5755103
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
    Stillström J
    Int J Cancer; 1974 Mar; 13(3):273-85. PubMed ID: 4362607
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy combined with primary resection of murine fibrosarcoma: correlation of immunological status of the host with prevention of metastases.
    Godrick EA; Michaelson JS; Vanwijck R; Wilson RE
    Ann Surg; 1972 Oct; 176(4):544-53. PubMed ID: 5077411
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H; Sun S; Iijima K; Gross MD
    Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
    Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship of immune status to the efficacy of immunotherapy in preventing tumour recurrence in mice.
    Levy JG; Whitney RB; Smith AG; Panno L
    Br J Cancer; 1974 Oct; 30(4):289-96. PubMed ID: 4447774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T; Maruyama Y; Good RA
    Natl Cancer Inst Monogr; 1972 Dec; 35():309-20. PubMed ID: 4572830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.